Frontline Therapy in Newly Diagnosed Advanced Hodgkin Lymphoma
There continues to be excitement among Hodgkin lymphoma specialists about the use of a new drug, Brentuximab Vedotin, with new early data... Learn More
Day
December 20, 2012